Annual CFF
$13.08 M
-$45.35 M-77.61%
December 31, 2024
Summary
- As of March 13, 2025, HOWL annual cash flow from financing activities is $13.08 million, with the most recent change of -$45.35 million (-77.61%) on December 31, 2024.
- During the last 3 years, HOWL annual CFF has fallen by -$96.35 million (-88.05%).
- HOWL annual CFF is now -88.05% below its all-time high of $109.43 million, reached on December 31, 2021.
Performance
HOWL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.55 M
+$2.55 M+42550.00%
December 31, 2024
Summary
- As of March 13, 2025, HOWL quarterly cash flow from financing activities is $2.55 million, with the most recent change of +$2.55 million (+42550.00%) on December 31, 2024.
- Over the past year, HOWL quarterly CFF has increased by +$2.55 million (+42550.00%).
- HOWL quarterly CFF is now -97.69% below its all-time high of $110.20 million, reached on June 30, 2021.
Performance
HOWL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$13.08 M
-$6.53 M-33.29%
December 31, 2024
Summary
- As of March 13, 2025, HOWL TTM cash flow from financing activities is $13.08 million, with the most recent change of -$6.53 million (-33.29%) on December 31, 2024.
- Over the past year, HOWL TTM CFF has dropped by -$6.53 million (-33.29%).
- HOWL TTM CFF is now -92.79% below its all-time high of $181.45 million, reached on June 30, 2021.
Performance
HOWL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HOWL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -77.6% | +10000.0% | -33.3% |
| 3 y3 years | -88.0% | +102.8% | -17.8% |
| 5 y5 years | -40.3% | +102.8% | -17.8% |
HOWL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.0% | at low | -94.8% | +126.2% | -88.1% | +292.1% |
| 5 y | 5-year | -88.0% | at low | -97.7% | +126.2% | -92.8% | -100.0% |
| alltime | all time | -88.0% | at low | -97.7% | +126.2% | -92.8% | -100.0% |
Werewolf Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $13.08 M(-77.6%) | $2.55 M(<-9900.0%) | $13.08 M(-33.3%) |
| Sep 2024 | - | -$6000.00(-99.9%) | $19.61 M(-0.2%) |
| Jun 2024 | - | -$9.72 M(-148.0%) | $19.65 M(-34.6%) |
| Mar 2024 | - | $20.26 M(+123.3%) | $30.07 M(-48.5%) |
| Dec 2023 | $58.43 M(+267.3%) | $9.07 M(>+9900.0%) | $58.43 M(+15.4%) |
| Sep 2023 | - | $41.00 K(-94.1%) | $50.61 M(-17.9%) |
| Jun 2023 | - | $692.00 K(-98.6%) | $61.65 M(-4.2%) |
| Mar 2023 | - | $48.62 M(+3771.3%) | $64.37 M(+304.7%) |
| Dec 2022 | $15.91 M | $1.26 M(-88.7%) | $15.91 M(+8.3%) |
| Sep 2022 | - | $11.08 M(+224.3%) | $14.69 M(+340.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $3.42 M(+2047.8%) | $3.34 M(-97.0%) |
| Mar 2022 | - | $159.00 K(+318.4%) | $110.12 M(+0.6%) |
| Dec 2021 | $109.43 M(+16.6%) | $38.00 K(-113.8%) | $109.43 M(-39.6%) |
| Sep 2021 | - | -$276.00 K(-100.3%) | $181.27 M(-0.1%) |
| Jun 2021 | - | $110.20 M(<-9900.0%) | $181.45 M(+94.4%) |
| Mar 2021 | - | -$538.00 K(-100.7%) | $93.32 M(-0.6%) |
| Dec 2020 | $93.86 M(+328.4%) | $71.88 M(<-9900.0%) | $93.86 M(+327.1%) |
| Sep 2020 | - | -$97.00 K(-100.4%) | $21.98 M(-0.4%) |
| Jun 2020 | - | $22.07 M(>+9900.0%) | $22.07 M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $21.91 M | - | - |
FAQ
- What is Werewolf Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual CFF year-on-year change?
- What is Werewolf Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly CFF year-on-year change?
- What is Werewolf Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM CFF year-on-year change?
What is Werewolf Therapeutics annual cash flow from financing activities?
The current annual CFF of HOWL is $13.08 M
What is the all time high annual CFF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual cash flow from financing activities is $109.43 M
What is Werewolf Therapeutics annual CFF year-on-year change?
Over the past year, HOWL annual cash flow from financing activities has changed by -$45.35 M (-77.61%)
What is Werewolf Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of HOWL is $2.55 M
What is the all time high quarterly CFF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly cash flow from financing activities is $110.20 M
What is Werewolf Therapeutics quarterly CFF year-on-year change?
Over the past year, HOWL quarterly cash flow from financing activities has changed by +$2.55 M (+42550.00%)
What is Werewolf Therapeutics TTM cash flow from financing activities?
The current TTM CFF of HOWL is $13.08 M
What is the all time high TTM CFF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM cash flow from financing activities is $181.45 M
What is Werewolf Therapeutics TTM CFF year-on-year change?
Over the past year, HOWL TTM cash flow from financing activities has changed by -$6.53 M (-33.29%)